The effect of a nicotine-rich diet with/without redistribution of dietary protein on motor indices in patients with Parkinson's disease: A randomized clinical trial.

What Was Tested

Researchers studied Therapeutic nicotine (patch, non-peptide) in the context of parkinson's disease in this randomized controlled trial publication.

The aim of designing this clinical trial is to investigate the impact of a nicotine-rich diet with/without protein redistribution on the motor indices of patients with Parkinson's disease (PD).

Who Took Part

The abstract describes 45 patients taking part.

The age groups tagged for this paper are middle-aged adults and older adults, both men and women.

In all group, the diet was isocaloric, and participants received six meals and snacks.

How the Study Was Run

The researchers set it up as a randomized study.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

Topics PubMed links to this paper include Parkinson Disease, alpha-Synuclein, Dietary Proteins, Nicotine, Apolipoprotein A-I and Cotinine.

The authors tagged it with the keywords Parkinson’s disease and Protein redistribution.

What This Means in Plain Language

The paper is a randomized study of Therapeutic nicotine (patch, non-peptide) in 45 patients in people with parkinson's disease.

Results are reported in around 9 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2024 (Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia), a journal based in Scotland.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, Parkinson's disease research.